| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.2 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.2 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |